Tofacitinib for refractory ocular mucous membrane pemphigoid-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tofacitinib for refractory ocular mucous membrane pemphigoid

Published:2021-06 Issue: Volume:22 Page:101104
ISSN:2451-9936
Container-title:American Journal of Ophthalmology Case Reports
language:en
Short-container-title:American Journal of Ophthalmology Case Reports

Author:

James Hayley^ORCID,Paley Grace L.^ORCID,Brasington Richard,Custer Philip L.,Margolis Todd P.,Paley Michael A.^ORCID

Funder

University of Washington

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Research to Prevent Blindness

National Institutes of Health

Rheumatology Research Foundation

Publisher

Elsevier BV

Subject

Ophthalmology

Reference24 articles.

1. Mucous membrane pemphigoid with ocular involvement: the clinical phenotype and its relationship to direct immunofluorescence findings;Ong;Ophthalmology,2018

2. Immunosuppressive therapy for ocular mucous membrane pemphigoid strategies and outcomes;Saw;Ophthalmology,2008

3. Ocular mucous membrane pemphigoid: current state of pathophysiology, diagnostics and treatment;Georgoudis;Ophthalmol Ther,2019

4. Cicatricial pemphigoid;Foster;Trans Am Ophthalmol Soc,1986

5. Adrenocorticotropic hormone analogue as novel treatment regimen in ocular cicatricial pemphigoid;Sharon;Am J Ophthalmol Case Rep,2018

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of baricitinib in acquired reactive perforating collagenosis: a case report;Frontiers in Immunology;2024-07-15

2. Inhibition of interferon gamma impairs induction of experimental epidermolysis bullosa acquisita;Frontiers in Immunology;2024-05-10

3. Real-Time Experience of Abrocitinib for the Treatment of Mucous Membrane Pemphigoid: A Case Report;Patient Preference and Adherence;2024-02

4. Tofacitinib for the treatment of severe rare skin diseases: a narrative review;European Journal of Clinical Pharmacology;2024-01-17

5. Advancing Treatment in Bullous Pemphigoid: A Comprehensive Review of Novel Therapeutic Targets and Approaches;Clinical Reviews in Allergy & Immunology;2023-10-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3